A detailed history of Stonnington Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Stonnington Group, LLC holds 6,300 shares of INCY stock, worth $440,433. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,300
Holding current value
$440,433
% of portfolio
0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

BUY
$70.23 - $86.01 $442,449 - $541,863
6,300 New
6,300 $455,000
Q2 2022

Jul 08, 2022

BUY
$66.18 - $83.18 $152,214 - $191,314
2,300 Added 43.4%
7,600 $614,000
Q1 2022

Apr 12, 2022

SELL
$66.02 - $79.71 $250,875 - $302,898
-3,800 Reduced 41.76%
5,300 $429,000
Q4 2021

Jan 12, 2022

BUY
$63.34 - $74.11 $576,394 - $674,401
9,100 New
9,100 $677,000
Q3 2021

Oct 12, 2021

SELL
$68.67 - $84.02 $391,419 - $478,914
-5,700 Closed
0 $0
Q2 2021

Jul 09, 2021

BUY
$79.87 - $87.53 $455,259 - $498,921
5,700 New
5,700 $464,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.